Cargando…
Anti-Epcam Aptamer (Syl3c)-Functionalized Liposome for Targeted Delivery Of Doxorubicin: In Vitro And In Vivo Antitumor Studies in Mice Bearing C26 Colon Carcinoma
In this study, we have surface-functionalized PEGylated-nanoliposomal doxorubicin (DOX) with anti-EpCAM (epithelial cell adhesion molecule) aptamer via post-insertion of anti-EpCAM aptamer-conjugated DSPE-mPEG(2000) into Caelyx® (ED-lip). The size, charge, release profile, and cytotoxicity and cellu...
Autores principales: | Mashreghi, Mohammad, Zamani, Parvin, Moosavian, Seyedeh Alia, Jaafari, Mahmoud Reza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7206479/ https://www.ncbi.nlm.nih.gov/pubmed/32383027 http://dx.doi.org/10.1186/s11671-020-03334-9 |
Ejemplares similares
-
Complex of C(60) Fullerene with Doxorubicin as a Promising Agent in Antitumor Therapy
por: Prylutska, Svitlana V., et al.
Publicado: (2015) -
Improved Antitumor Efficacy and Pharmacokinetics of Bufalin via PEGylated Liposomes
por: Yuan, Jiani, et al.
Publicado: (2017) -
Designing Aptamer-Gold Nanoparticle-Loaded pH-Sensitive Liposomes Encapsulate Morin for Treating Cancer
por: Ding, Xiaoyuan, et al.
Publicado: (2020) -
Bufalin-Loaded PEGylated Liposomes: Antitumor Efficacy, Acute Toxicity, and Tissue Distribution
por: Yuan, Jiani, et al.
Publicado: (2019) -
Triphenyl Phosphine-Functionalized Chitosan Nanoparticles Enhanced Antitumor Efficiency Through Targeted Delivery of Doxorubicin to Mitochondria
por: Hou, Jiahui, et al.
Publicado: (2017)